Associated Papers
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Hayes TK et al.
Nature Communications, 2024
38548752 (PubMed )
Supplement: 41467_2024_45594_MOESM4_ESM.xlsx › All
Sitravatinib is a potential EGFR inhibitor and induce a new death phenotype in Glioblastoma.
Lu H et al.
Investigational New Drugs, 2023
Treatment Strategies for Non-Small Cell Lung Cancer Harboring Common and Uncommon EGFR Mutations: Drug Sensitivity Based on Exon Classification, and Structure-Function Analysis.
Kitadai R et al.
Cancers, 2022
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC.
Wei J et al.
Targeted Oncology, 2021
33606136 (PubMed )
Supplement: 11523_2021_798_MOESM1_ESM.pdf
Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease.
Marjanovic I et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2016
Select a paper to view details